FreeTender
Accepting bidsrfqRussia

Поставка лекарственных препаратов на 2027 год_ Онкогематология_РЛО Ибрутиниб 2

The supply of medicines for 2027 Oncohematology RLO Ibrutinib 2English, machine translated

Issued by КОМИТЕТ ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ РЕСПУБЛИКИ ДАГЕСТАН · via Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
28 Oct 2026
Closes
9 Nov 2026, 04:00 UTC
Value
RUB 19,081,534.5
Reference
0103200008426008704
Location
Республика Дагестан, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

КОМИТЕТ ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ РЕСПУБЛИКИ ДАГЕСТАН in Russia has published a request for quotations in healthcare & pharma: “Поставка лекарственных препаратов на 2027 год_ Онкогематология_РЛО Ибрутиниб 2”. Submissions close on 9 November 2026, 12 days from today. The stated value is RUB 19,081,534.5. Quote reference 0103200008426008704 in any correspondence with the buyer. FreeTender has recorded 400 notices from this buyer since 2026, 212 of them currently open. There are 21,202 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Subject matter of procurement: 1. ibrutinib, capsules 140 mg (OKPD2 21.20.10.211 - Antitumor drugs), 4 050 pieces Law: 44-FZ. Purchase method: Request for quotations. Site: JSC "Sberbank-AST". Initial (maximum) price: 19,081,534.50 . Organizer: Public Procurement Committee of the Republic of Daghestan. Region: Republic of Dagestan. Acceptance of applications until: 09.11.2026 07:00 (MSK). Notice to the EIS: https://zakupki.gov.ru/epz/order/notice/view/common-info.html?regNumber=0103200008426008704

Details

Поставка лекарственных препаратов на 2027 год_ Онкогематология_РЛО Ибрутиниб 2

Объект закупки:

1. ибрутиниб, капсулы 140 мг (ОКПД2 21.20.10.211 – Препараты противоопухолевые), 4 050 шт Закон: 44-ФЗ. Способ закупки: Запрос котировок. Площадка: АО «Сбербанк-АСТ». Начальная (максимальная) цена: 19 081 534.50 ₽. Организатор: КОМИТЕТ ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ РЕСПУБЛИКИ ДАГЕСТАН. Регион: Республика Дагестан. Приём заявок до: 09.11.2026 07:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/view/common-info.html?regNumber=0103200008426008704

Context for bidders

We hold 400 notices from КОМИТЕТ ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ РЕСПУБЛИКИ ДАГЕСТАН, going back to October 2026 — 212 of them still open. They buy mostly in Healthcare & Pharma, Agriculture & Food and Manufacturing & Supply. There are 21,202 open Healthcare & Pharma tenders in Russia. This one closes in 12 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →